Search

everythinglearnresearchcommunity

for

Search:↓

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Effective treatments for severe alopecia areata are still lacking.

Macrophages help maintain mammary stem cells and tissue balance through specific signaling pathways.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Careful medical care is needed for those over 50 on hormone therapy during COVID-19.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Chicken feather gene mutation helps understand human hair disorders.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

Topical vitamin D is effective in treating vitiligo with few side effects.

TNF-alpha inhibitors can cause various immune-related skin issues.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

TLR2 is important for hair growth and can be targeted to treat hair loss.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.